Your browser doesn't support javascript.
loading
RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.
Wang, Yifan; Gudikote, Jayanthi; Giri, Uma; Yan, Jun; Deng, Weiye; Ye, Rui; Jiang, Wen; Li, Nan; Hobbs, Brian P; Wang, Jing; Swisher, Stephen G; Fujimoto, Junya; Wistuba, Ignacio I; Komaki, Ritsuko; Heymach, John V; Lin, Steven H.
Afiliação
  • Wang Y; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Gudikote J; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
  • Giri U; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yan J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Deng W; Oncology Research for Biologics and Immunotherapy Translation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ye R; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jiang W; The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences, Houston, Texas.
  • Li N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hobbs BP; Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Swisher SG; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fujimoto J; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Komaki R; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Heymach JV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lin SH; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 24(2): 341-350, 2018 01 15.
Article em En | MEDLINE | ID: mdl-29030353

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Expressão Gênica / Carcinoma Pulmonar de Células não Pequenas / Enzimas Reparadoras do DNA / Proteínas de Ligação a DNA / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Expressão Gênica / Carcinoma Pulmonar de Células não Pequenas / Enzimas Reparadoras do DNA / Proteínas de Ligação a DNA / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos